Peritonitis and Abdominal Sepsis Clinical Presentation
- Author: Brian James Daley, MD, MBA, FACS, FCCP, CNSC; Chief Editor: Julian Katz, MD more...
History
The diagnosis of peritonitis is usually clinical. History should include recent abdominal surgery, previous episodes of peritonitis, travel history, use of immunosuppressive agents, and the presence of diseases (eg, inflammatory bowel disease, diverticulitis, peptic ulcer disease) that may predispose to intra-abdominal infections.
A broad range of signs and symptoms are seen in spontaneous bacterial peritonitis (SBP). A high index of suspicion must be maintained when caring for patients with ascites, particularly those with acute clinical deterioration. As many as 30% of patients are completely asymptomatic. Manifestations of SBP may include the following:
- Fever and chills (as many as 80% of patients)
- Abdominal pain or discomfort (found in as many as 70% of patients)
- Worsening or unexplained encephalopathy
- Diarrhea
- Ascites that does not improve following administration of diuretic medication
- Worsening or new-onset renal failure
- Ileus
Abdominal pain, which may be acute or insidious, is the usual chief complaint of patients with peritonitis. Initially, the pain may be dull and poorly localized (visceral peritoneum); often, it progresses to steady, severe, and more localized pain (parietal peritoneum). Abdominal pain may be exacerbated by any movement (eg, coughing, flexing the hips) and local pressure. If the underlying process is not contained, the pain becomes diffuse. In certain disease entities (eg, gastric perforation, severe acute pancreatitis, intestinal ischemia), the abdominal pain may be generalized from the beginning.
Abdominal distention may be noted, as well as signs of dysfunction of other organs. Symptoms may be subtle in patients on corticosteroids, in diabetic patients with advanced neuropathy, and in hospitalized patients, especially the very young and the very old. In the presence of ascites, decreased friction between the visceral and parietal peritoneal surfaces may reduce the symptoms of abdominal pain, as seen in patients with SBP.
Anorexia and nausea are frequent symptoms and may precede the development of abdominal pain. Vomiting may be due to underlying visceral organ pathology (ie, obstruction) or be secondary to peritoneal irritation.
Physical Examination
On physical examination, patients with peritonitis generally appear unwell and in acute distress. Many of them have a temperature that exceeds 38° C, although patients with severe sepsis may become hypothermic. Tachycardia may be present, as a result of the release of inflammatory mediators, intravascular hypovolemia from anorexia vomiting and fever, and third-space losses into the peritoneal cavity. With progressive dehydration, patients may become hypotensive (5-14% of patients), as well as oliguric or anuric; with severe peritonitis, they may present in overt septic shock.
When examining the abdomen of a patient with suspected peritonitis, the patient should be supine. A roll or pillows underneath the patient's knees may allow for better relaxation of the abdominal wall.
On abdominal examination, almost all patients demonstrate tenderness to palpation. In most patients—even those with generalized peritonitis and severe diffuse abdominal pain—the point of maximal tenderness or referred rebound tenderness roughly overlies the pathologic process (ie, the site of maximal peritoneal irritation).
Most patients demonstrate increased abdominal wall rigidity. The increase in abdominal wall muscular tone may be voluntary, in response to or in anticipation of the abdominal examination, or involuntary because of the peritoneal irritation. Patients with severe peritonitis often avoid all motion and keep their hips flexed to relieve the abdominal wall tension. The abdomen is often distended, with hypoactive-to-absent bowel sounds. This finding reflects a generalized ileus and may not be present if the infection is well localized. Occasionally, the abdominal examination reveals an inflammatory mass.
Signs of hepatic failure (eg, jaundice, angiomata) may be noted.
Rectal examination often elicits increased abdominal pain, particularly with inflammation of the pelvic organs, but rarely indicates a specific diagnosis. A tender inflammatory mass toward the right may indicate appendicitis, and anterior fullness and fluctuation may indicate a cul de sac abscess.
In female patients, vaginal and bimanual examination findings may be consistent with pelvic inflammatory disease (eg, endometritis, salpingo-oophoritis, tubo-ovarian abscess), but exam findings are often difficult to interpret in severe peritonitis.
A complete physical examination is important for excluding conditions whose presentation may resemble that of peritonitis. Thoracic processes with diaphragmatic irritation (eg, empyema), extraperitoneal processes (eg, pyelonephritis, cystitis, acute urinary retention), and abdominal wall processes (eg, infection, rectus hematoma) may mimic certain signs and symptoms of peritonitis. Always examine the patient for the presence of external hernias to rule out intestinal incarceration.
Remember that the presentation and the findings on clinical examination may be entirely inconclusive or unreliable in patients with significant immunosuppression (eg, severe diabetes, steroid use, posttransplant status, HIV infection), in patients with altered mental state (eg, head injury, toxic encephalopathy, septic shock, analgesic agents), in patients with paraplegia, and in patients of advanced age. With localized deep peritoneal infections, fever and/or an elevated WBC count may be the only signs present. As many as 20% of patients with SBP demonstrate very subtle signs and symptoms. New onset or deterioration of existing encephalopathy may be the only sign of the infection at the initial presentation. Most patients with TP demonstrate vague symptoms and may be afebrile.
Pavlidis TE. Cellular changes in association with defense mechanisms in intra-abdominal sepsis. Minerva Chir. Dec 2003;58(6):777-81. [Medline].
Appenrodt B, Grünhage F, Gentemann MG, Thyssen L, Sauerbruch T, Lammert F. Nucleotide-binding oligomerization domain containing 2 (NOD2) variants are genetic risk factors for death and spontaneous bacterial peritonitis in liver cirrhosis. Hepatology. Apr 2010;51(4):1327-33. [Medline].
Barretti P, Montelli AC, Batalha JE, Caramori JC, Cunha Mde L. The role of virulence factors in the outcome of staphylococcal peritonitis in CAPD patients. BMC Infect Dis. Dec 22 2009;9:212. [Medline]. [Full Text].
[Guideline] Runyon BA. Management of adult patients with ascites due to cirrhosis. Hepatology. Mar 2004;39(3):841-56. [Medline].
Lata J, Stiburek O, Kopacova M. Spontaneous bacterial peritonitis: a severe complication of liver cirrhosis. World J Gastroenterol. Nov 28 2009;15(44):5505-10. [Medline]. [Full Text].
Bert F, Noussair L, Lambert-Zechovsky N, Valla D. Viridans group streptococci: an underestimated cause of spontaneous bacterial peritonitis in cirrhotic patients with ascites. Eur J Gastroenterol Hepatol. Sep 2005;17(9):929-33. [Medline].
Cholongitas E, Papatheodoridis GV, Lahanas A, Xanthaki A, Kontou-Kastellanou C, Archimandritis AJ. Increasing frequency of Gram-positive bacteria in spontaneous bacterial peritonitis. Liver Int. Feb 2005;25(1):57-61. [Medline].
Adler SN, Gasbarra DB. A Pocket Manual of Differential Diagnosis. Philadelphia, Pa: Lippincott Williams & Wilkins; 2005.
Nouri-Majalan N, Najafi I, Sanadgol H, Ganji MR, Atabak S, Hakemi M, et al. Description of an outbreak of acute sterile peritonitis in Iran. Perit Dial Int. Jan-Feb 2010;30(1):19-22. [Medline].
Evans LT, Kim WR, Poterucha JJ, Kamath PS. Spontaneous bacterial peritonitis in asymptomatic outpatients with cirrhotic ascites. Hepatology. Apr 2003;37(4):897-901. [Medline].
Cheruvattath R, Balan V. Infections in Patients With End-stage Liver Disease. J Clin Gastroenterol. Apr 2007;41(4):403-11. [Medline].
Soriano G, Castellote J, Alvarez C, et al. Secondary bacterial peritonitis in cirrhosis: a retrospective study of clinical and analytical characteristics, diagnosis and management. J Hepatol. Jan 2010;52(1):39-44. [Medline].
Marshall JC. Intra-abdominal infections. Microbes Infect. Sep 2004;6(11):1015-25. [Medline].
Riggio O, Angeloni S. Ascitic fluid analysis for diagnosis and monitoring of spontaneous bacterial peritonitis. World J Gastroenterol. Aug 21 2009;15(31):3845-50. [Medline]. [Full Text].
Gaya DR, David B Lyon T, Clarke J, Jamdar S, Inverarity D, Forrest EH, et al. Bedside leucocyte esterase reagent strips with spectrophotometric analysis to rapidly exclude spontaneous bacterial peritonitis: a pilot study. Eur J Gastroenterol Hepatol. Apr 2007;19(4):289-95. [Medline].
Blot S, De Waele JJ. Critical issues in the clinical management of complicated intra-abdominal infections. Drugs. 2005;65(12):1611-20. [Medline].
Hawker FH. How to feed patients with sepsis. Curr Opin Crit Care. Aug 2000;6(4):247-252. [Medline].
Runyon B. Ascites and spontaneous bacterial peritonitis. In: Feldman M, Friedman LS, Sleisenger MH, eds. Sleisenger & Fordtran's Gastrointestinal and Liver Disease. Vol 2. 8th ed. Philadelphia, Pa: Saunders; 2006:1935-64.
Colizza S, Rossi S. Antibiotic prophylaxis and treatment of surgical abdominal sepsis. J Chemother. Nov 2001;13 Spec No 1(1):193-201. [Medline].
Ginés P, Rimola A, Planas R, Vargas V, et al. Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial. Hepatology. Oct. 1990;12(4 Pt 1):716-24.
Soares-Weiser K, Brezis M, Leibovici L. Antibiotics for spontaneous bacterial peritonitis in cirrhotics. Cochrane Database Syst Rev. 2001;CD002232. [Medline].
Tubau F, Liñares J, Rodríguez MD, Cercenado E, Aldea MJ, González-Romo F, et al. Susceptibility to tigecycline of isolates from samples collected in hospitalized patients with secondary peritonitis undergoing surgery. Diagn Microbiol Infect Dis. Mar 2010;66(3):308-13. [Medline].
[Best Evidence] Wiggins KJ, Craig JC, Johnson DW, Strippoli GF. Treatment for peritoneal dialysis-associated peritonitis. Cochrane Database Syst Rev. Jan 23 2008;CD005284. [Medline].
| Source Regions | Causes |
| Esophagus | Boerhaave syndrome Malignancy Trauma (mostly penetrating) Iatrogenic* |
| Stomach | Peptic ulcer perforation Malignancy (eg, adenocarcinoma, lymphoma, gastrointestinal stromal tumor) Trauma (mostly penetrating) Iatrogenic* |
| Duodenum | Peptic ulcer perforation Trauma (blunt and penetrating) Iatrogenic* |
| Biliary tract | Cholecystitis Stone perforation from gallbladder (ie, gallstone ileus) or common duct Malignancy Choledochal cyst (rare) Trauma (mostly penetrating) Iatrogenic* |
| Pancreas | Pancreatitis (eg, alcohol, drugs, gallstones) Trauma (blunt and penetrating) Iatrogenic* |
| Small bowel | Ischemic bowel Incarcerated hernia (internal and external) Closed loop obstruction Crohn disease Malignancy (rare) Meckel diverticulum Trauma (mostly penetrating) |
| Large bowel and appendix | Ischemic bowel Diverticulitis Malignancy Ulcerative colitis and Crohn disease Appendicitis Colonic volvulus Trauma (mostly penetrating) Iatrogenic |
| Uterus, salpinx, and ovaries | Pelvic inflammatory disease (eg, salpingo-oophoritis, tubo-ovarian abscess, ovarian cyst) Malignancy (rare) Trauma (uncommon) |
| *Iatrogenic trauma to the upper GI tract, including the pancreas and biliary tract and colon, often results from endoscopic procedures; anastomotic dehiscence and inadvertent bowel injury (eg, mechanical, thermal) are common causes of leak in the postoperative period. | |
| Type | Organism | Percentage |
| Aerobic | ||
| Gram negative | Escherichia coli | 60% |
| Enterobacter/Klebsiella | 26% | |
| Proteus | 22% | |
| Pseudomonas | 8% | |
| Gram positive | Streptococci | 28% |
| Enterococci | 17% | |
| Staphylococci | 7% | |
| Anaerobic | Bacteroides | 72% |
| Eubacteria | 24% | |
| Clostridia | 17% | |
| Peptostreptococci | 14% | |
| Peptococci | 11% | |
| Fungi | Candida | 2% |
| Peritonitis (Type) | Etiologic Organisms | Antibiotic Therapy (Suggested) | |
| Class | Type of Organism | ||
| Primary | Gram-negative | E coli (40%) K pneumoniae (7%) Pseudomonas species (5%) Proteus species (5%) Streptococcus species (15%) Staphylococcus species (3%) Anaerobic species (< 5%) | Third-generation cephalosporin |
| Secondary | Gram-negative | E coli Enterobacter species Klebsiella species Proteus species | Second-generation cephalosporin Third-generation cephalosporin Penicillins with anaerobic activity Quinolones with anaerobic activity Quinolone and metronidazole Aminoglycoside and metronidazole |
| Gram-positive | Streptococcus species Enterococcus species | ||
| Anaerobic | Bacteroides fragilis Other Bacteroides species Eubacterium species Clostridium species Anaerobic Streptococcus species | ||
| Tertiary | Gram-negative | Enterobacter species Pseudomonas species Enterococcus species | Second-generation cephalosporin Third-generation cephalosporin Penicillins with anaerobic activity Quinolones with anaerobic activity Quinolone and metronidazole Aminoglycoside and metronidazole Carbapenems Triazoles or amphotericin (considered in fungal etiology) (Alter therapy based on culture results.) |
| Gram-positive | Staphylococcus species | ||
| Fungal | Candida species | ||
| Routine | Optional | Unusual | Less Helpful |
| Cell count | Obtain culture in blood culture (BC) bottles. | Tuberculosis (TB) smear and culture | pH |
| Albumin | Glucose | Cytology | Lactate |
| Total protein | Lactate dehydrogenase (LDH) | Triglyceride | Cholesterol |
| Amylase | Bilirubin | Fibronectin | |
| Gram stain | Alpha 1-antitrypsin | ||
| Glycosaminoglycans |

